Indeed, Zhang et al. have reported that TIGAR upregulation correlates with an aggressive disease phenotype in cervical cancer patients as determined by fluorine-18-fluorodeoxyglucose PET/computed tomography scans [62]. The gene discussed is TIGAR; the disease is cervical carcinoma.